Full title: A Study to Investigate Velzatinib (GSK6042981) Compared With Imatinib in Adult Participants With Previously Untreated Metastatic and/or Unresectable Gastrointestinal Stromal Tumors (StrateGIST Frontline)
Age: 18+ years
Phase: 3
Locations:
- Liverpool– The Clatterbridge Cancer Centre
- London – University College London Hospital, Royal Marsden Hospital
- Manchester – The Christie
- Newcastle – Freeman Hospital
- Oxford – Oxford University Hospital
- Sheffield – Great Northern General Hospital
Brief summary:
This study is a phase 3 trial looking at whether a new drug, called velzatinib (GSK6042981), is effective in treating adults newly diagnosed with Gastrointestinal Stromal Tumours (GIST) that have spread or cannot be surgically removed. Velzatinib will be compared to another drug called imatinib. Researchers want to know whether velzatinib can stop a person’s disease from getting worse and to see if it is safe.
More information can be found at clinicaltrials.gov
To find out more about this trial and whether you could take part, talk to your clinical team.
